Compared to other biomarkers, a recent randomized controlled trial confirmed CRP to be a robust parameter for differentiating between septic and non-septic patients with systemic inflammatory response syndrome (SIRS) [22]. This evidence concerns the gene CRP and systemic inflammatory response syndrome.